Author

S. K. Subudhi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Deswal· 1 shared A. Futreal· 1 shared A. M. Aparicio· 1 shared A. Rawther-Karedath· 1 shared B. A. Siddiqui· 1 shared C. A. Iliescu· 1 shared C. J. Logothetis· 1 shared E. Labanca· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Deswal

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular pathways and cellular subsets associated with adverse clinical outcomes in overlapping immune-related myocarditis and myositis

B. A. Siddiqui, N. L. Palaskas, S. Basu, Y. Dai, Z. He, S. S. Yadav, J. Allison, R. Sheth, S. Tummala, L. M. Buja, M. Bhattacharjee, C. A. Iliescu, A. Rawther-Karedath, A. Deswal, L. Wang, , S. K. Subudhi

The paper uses single-cell RNA sequencing to identify molecular pathways and immune subsets in immune-related myocarditis and myositis, finding clonally expanded CD8+ T cells and specific myeloid cell populations associated with adverse outcomes.

bioRxiv · Sep 15, 2023Immunology

Integrative analysis of the MD Anderson Prostate Cancer Patient-Derived Xenograft Series (MDA PCa PDX)

N. Anselmino, E. Labanca, X. Song, J. Yang, P. D. Shepherd, J. Dong, R. Kundra, N. Schultz, J. Zhang, J. C. Araujo, A. M. Aparicio, S. K. Subudhi, P. G. Corn, L. L. Pisters, J. F. Ward, , N. M. Navone

The paper characterizes the genomic and transcriptomic landscape of MDA PCa PDX models and develops an organoid platform to study prostate cancer heterogeneity and resistance.

bioRxiv · Jul 21, 2022 · PreprintCancer Biology